Enzymotec (Enzymotec) Total Liabilities : $16.11 Mil (As of Sep. 2017)

View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Total Liabilities?

Enzymotec's Total Liabilities for the quarter that ended in Sep. 2017 was $16.11 Mil.

Enzymotec's quarterly Total Liabilities increased from Mar. 2017 ($10.72 Mil) to Jun. 2017 ($12.39 Mil) and increased from Jun. 2017 ($12.39 Mil) to Sep. 2017 ($16.11 Mil).

Enzymotec's annual Total Liabilities increased from Dec. 2014 ($9.98 Mil) to Dec. 2015 ($12.21 Mil) but then declined from Dec. 2015 ($12.21 Mil) to Dec. 2016 ($10.35 Mil).

Enzymotec Total Liabilities Historical Data

The historical data trend for Enzymotec's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Total Liabilities Chart

Enzymotec Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Total Liabilities

Get a 7-Day Free Trial

16.79

18.47

9.98

12.21

10.35

Enzymotec Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Total Liabilities	Get a 7-Day Free Trial															13.33	10.35	10.72	12.39	16.11

Enzymotec Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Enzymotec's Total Liabilities for the fiscal year that ended in Dec. 2016 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.929	+	(0	+	1.7763568394003E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1.42)
	=	10.35

Total Liabilities	=	Total Assets (A: Dec. 2016 )	-	Total Equity (A: Dec. 2016 )
	=	146.949	-	136.6
	=	10.35

Enzymotec's Total Liabilities for the quarter that ended in Sep. 2017 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.628	+	(0	+	-5.3290705182008E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1.484)
	=	16.11

Total Liabilities	=	Total Assets (Q: Sep. 2017 )	-	Total Equity (Q: Sep. 2017 )
	=	155.542	-	139.43
	=	16.11

Enzymotec Total Liabilities Related Terms

Thank you for viewing the detailed overview of Enzymotec's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymotec (Enzymotec) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.enzymotec.com

Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015